Home DailyMed f6cf2aaa-5aeb-4a63-b040-4be0b65eb879 National Council for Prescription Drug Programs indexing - billing unit Drug label information. FDA.report displays public Structured Product Labeling data from DailyMed and legacy FDA.report DailyMed cache rows. This page is not medical advice, prescribing advice, or a substitute for the official label reviewed by a qualified healthcare professional. Labeling can change; when a current hydrated DailyMed SPL record is available, FDA.report shows that newer record before legacy cached files.
Manufacturer National Council for Prescription Drug Programs
Effective date 2012-07-24
Label type Indexing - Billing Unit
Version 1
Source full-release
Hydrated at 2026-06-05 03:06:08 Orange Book application contexts# All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book application contexts page 1 of 1 · 1 matching rows.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 11 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021540-001 CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 5MG BASE;EQ 10MG BASE TABLET / ORAL AB RLD 2004-01-30 N021540-002 CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 5MG BASE;EQ 20MG BASE TABLET / ORAL AB RLD 2004-01-30 N021540-003 CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 5MG BASE;EQ 40MG BASE TABLET / ORAL AB RLD 2004-01-30 N021540-004 CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 5MG BASE;EQ 80MG BASE TABLET / ORAL AB RLD 2004-01-30 N021540-005 CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 10MG BASE;EQ 10MG BASE TABLET / ORAL AB RLD 2004-01-30 N021540-006 CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 10MG BASE;EQ 20MG BASE TABLET / ORAL AB RLD 2004-01-30 N021540-007 CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 10MG BASE;EQ 40MG BASE TABLET / ORAL AB RLD 2004-01-30 N021540-008 CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 10MG BASE;EQ 80MG BASE TABLET / ORAL AB RLD, RS 2004-01-30 N021540-009 CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 2.5MG BASE;EQ 10MG BASE TABLET / ORAL AB RLD 2004-07-29 N021540-010 CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 2.5MG BASE;EQ 20MG BASE TABLET / ORAL AB RLD 2004-07-29 N021540-011 CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 2.5MG BASE;EQ 40MG BASE TABLET / ORAL AB RLD 2004-07-29
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 11 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 12 · 473 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N021540-001 CADUET EQ 5MG BASE;EQ 10MG BASE TABLET / ORAL AB RLD 2004-01-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021540-002 CADUET EQ 5MG BASE;EQ 20MG BASE TABLET / ORAL AB RLD 2004-01-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021540-003 CADUET EQ 5MG BASE;EQ 40MG BASE TABLET / ORAL AB RLD 2004-01-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021540-004 CADUET EQ 5MG BASE;EQ 80MG BASE TABLET / ORAL AB RLD 2004-01-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021540-005 CADUET EQ 10MG BASE;EQ 10MG BASE TABLET / ORAL AB RLD 2004-01-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021540-006 CADUET EQ 10MG BASE;EQ 20MG BASE TABLET / ORAL AB RLD 2004-01-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021540-007 CADUET EQ 10MG BASE;EQ 40MG BASE TABLET / ORAL AB RLD 2004-01-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021540-008 CADUET EQ 10MG BASE;EQ 80MG BASE TABLET / ORAL AB RLD, RS 2004-01-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021540-009 CADUET EQ 2.5MG BASE;EQ 10MG BASE TABLET / ORAL AB RLD 2004-07-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021540-010 CADUET EQ 2.5MG BASE;EQ 20MG BASE TABLET / ORAL AB RLD 2004-07-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021540-011 CADUET EQ 2.5MG BASE;EQ 40MG BASE TABLET / ORAL AB RLD 2004-07-29 84e616aacf4f…2026-08-18 06:07:40 2026-07 N021540-001 CADUET EQ 5MG BASE;EQ 10MG BASE TABLET / ORAL AB RLD 2004-01-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021540-002 CADUET EQ 5MG BASE;EQ 20MG BASE TABLET / ORAL AB RLD 2004-01-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021540-003 CADUET EQ 5MG BASE;EQ 40MG BASE TABLET / ORAL AB RLD 2004-01-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021540-004 CADUET EQ 5MG BASE;EQ 80MG BASE TABLET / ORAL AB RLD 2004-01-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021540-005 CADUET EQ 10MG BASE;EQ 10MG BASE TABLET / ORAL AB RLD 2004-01-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021540-006 CADUET EQ 10MG BASE;EQ 20MG BASE TABLET / ORAL AB RLD 2004-01-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021540-007 CADUET EQ 10MG BASE;EQ 40MG BASE TABLET / ORAL AB RLD 2004-01-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021540-008 CADUET EQ 10MG BASE;EQ 80MG BASE TABLET / ORAL AB RLD, RS 2004-01-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021540-009 CADUET EQ 2.5MG BASE;EQ 10MG BASE TABLET / ORAL AB RLD 2004-07-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021540-010 CADUET EQ 2.5MG BASE;EQ 20MG BASE TABLET / ORAL AB RLD 2004-07-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021540-011 CADUET EQ 2.5MG BASE;EQ 40MG BASE TABLET / ORAL AB RLD 2004-07-29 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N021540-001 CADUET EQ 5MG BASE;EQ 10MG BASE TABLET / ORAL AB RLD 2004-01-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021540-002 CADUET EQ 5MG BASE;EQ 20MG BASE TABLET / ORAL AB RLD 2004-01-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021540-003 CADUET EQ 5MG BASE;EQ 40MG BASE TABLET / ORAL AB RLD 2004-01-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021540-004 CADUET EQ 5MG BASE;EQ 80MG BASE TABLET / ORAL AB RLD 2004-01-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021540-005 CADUET EQ 10MG BASE;EQ 10MG BASE TABLET / ORAL AB RLD 2004-01-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021540-006 CADUET EQ 10MG BASE;EQ 20MG BASE TABLET / ORAL AB RLD 2004-01-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021540-007 CADUET EQ 10MG BASE;EQ 40MG BASE TABLET / ORAL AB RLD 2004-01-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021540-008 CADUET EQ 10MG BASE;EQ 80MG BASE TABLET / ORAL AB RLD, RS 2004-01-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021540-009 CADUET EQ 2.5MG BASE;EQ 10MG BASE TABLET / ORAL AB RLD 2004-07-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021540-010 CADUET EQ 2.5MG BASE;EQ 20MG BASE TABLET / ORAL AB RLD 2004-07-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021540-011 CADUET EQ 2.5MG BASE;EQ 40MG BASE TABLET / ORAL AB RLD 2004-07-29 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021540-001 CADUET EQ 5MG BASE;EQ 10MG BASE TABLET / ORAL AB RLD 2004-01-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021540-002 CADUET EQ 5MG BASE;EQ 20MG BASE TABLET / ORAL AB RLD 2004-01-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021540-003 CADUET EQ 5MG BASE;EQ 40MG BASE TABLET / ORAL AB RLD 2004-01-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021540-004 CADUET EQ 5MG BASE;EQ 80MG BASE TABLET / ORAL AB RLD 2004-01-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021540-005 CADUET EQ 10MG BASE;EQ 10MG BASE TABLET / ORAL AB RLD 2004-01-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021540-006 CADUET EQ 10MG BASE;EQ 20MG BASE TABLET / ORAL AB RLD 2004-01-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021540-007 CADUET EQ 10MG BASE;EQ 40MG BASE TABLET / ORAL AB RLD 2004-01-30 31067a03dcf5…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 12 · 473 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.